Trademarkia Logo

Australia

AU$
ZOLGENSMA INCAL
Protected: Registered/protected

Last updated on 29 Jun 2024

Owner Info

Novartis AG

CH-4002 Basel

SWITZERLAND,

Serial Number

2438662 filed on 29 Jan 2024

Correspondent

Novartis Pharma AG, Trademark Department

Postfach,

CH-4002 Basel,

SWITZERLAND

ZOLGENSMA INCAL

Classification Information


Class [005]
Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or ne Read More

Mark Details


Serial Number

2438662

Registered On

29 Jan 2024

Renewal On

29 Jan 2034

Mark Type

WORD

Priority Claim (Convention Details)


Date

20 Nov 2023

Mark Type

CH

Legal History


Show more

Status DateAction Taken
29th Jun 2024International Registration in Australia Protected correspondence sent
28th Jun 2024IP Right Registration Published
28th Jun 2024Status change to Registered/Protected
21st Apr 2024Application Accepted correspondence sent
21st Apr 2024IP Right has been Examined
21st Apr 2024IP Right Acceptance Published
8th Apr 2024Status change to Accepted
2th Apr 2024Examination expedited
2th Apr 2024Awaiting examination
28th Mar 2024IP Right Filed Published